Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Jorge Matías-Guiu and Paloma Montero-Escribano.
Jorge Matías-Guiu
Connection Strength
1.386
Paloma Montero-Escribano
  1. Clinical exacerbation of SARS-CoV2 infection after fingolimod withdrawal. J Med Virol. 2021 01; 93(1):546-549.
    View in: PubMed
    Score: 0.223
  2. SARS-CoV-2 as a Potential Trigger of Neurodegenerative Diseases. Mov Disord. 2020 07; 35(7):1104-1105.
    View in: PubMed
    Score: 0.223
  3. Should We Adapt the Prescription Criteria for Specific Treatments for Migraine Due to the COVID-19 Pandemic? Headache. 2020 07; 60(7):1448-1449.
    View in: PubMed
    Score: 0.222
  4. Potential COVID-19 infection in patients with severe multiple sclerosis treated with alemtuzumab. Mult Scler Relat Disord. 2020 Sep; 44:102297.
    View in: PubMed
    Score: 0.222
  5. Is the brain a reservoir organ for SARS-CoV2? J Med Virol. 2020 11; 92(11):2354-2355.
    View in: PubMed
    Score: 0.221
  6. Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid, Spain. Mult Scler Relat Disord. 2020 07; 42:102185.
    View in: PubMed
    Score: 0.220
  7. ACE2, TMPRSS2, and Furin variants and SARS-CoV-2 infection in Madrid, Spain. J Med Virol. 2021 02; 93(2):863-869.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.